Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

Jacobien M. Kieffer*, Tjeerd J. Postma, Lonneke van de Poll-Franse, Floortje Mols, Jan J. Heimans, Guido Cavaletti, CI-PeriNomS Grp, Roy Lalisang, Neil K. Aaronson

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2999-3010
Number of pages12
JournalQuality of Life Research
Volume26
Issue number11
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Chemotherapy-induced peripheral neuropathy
  • Factor analysis
  • Measurement model
  • Symptom checklist
  • QUALITY-OF-LIFE
  • CAUSAL INDICATORS
  • OUTCOME MEASURES
  • CANCER-TREATMENT
  • ADVERSE EVENTS
  • NEUROTOXICITY
  • PATIENT
  • ONCOLOGY
  • MANAGEMENT
  • CRITERIA

Cite this

Kieffer, J. M., Postma, T. J., van de Poll-Franse, L., Mols, F., Heimans, J. J., Cavaletti, G., CI-PeriNomS Grp, Lalisang, R., & Aaronson, N. K. (2017). Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Quality of Life Research, 26(11), 2999-3010. https://doi.org/10.1007/s11136-017-1626-1